Posts by Sandra Ansanay-Alex
Global Innovation Summit 2026
The Global Innovation Summit 2026 is taking place on 6 May 2026 in Basel and is the opportunity to kick off your innovation project with international partners, strengthen your business and explore suitable funding opportunities in over 40 countries. The Global Innovation Summit is a recurring gathering organised in the framework of Eureka the world’s largest network…
Read MoreTakeda Unveils New State-of-the-Art Biotech Facility in Neuchâtel
Japonese company Takeda has reached an important milestone in Western Switzerland with the inauguration of a new aseptic filling facility in Neuchâtel — a major investment that strengthens both regional innovation and global access to life-changing therapies. With more than CHF 200 Million invested, this is the largest expansion ever made at the site. Boosting…
Read MoreArtiria Medical Secures CE Mark for it SmartGUIDE™ 014, a Deflectable Guidewire
Artiria Medical, an EPFL spinoff and Swiss innovator in neurovascular technologies, announces that its SmartGUIDE™ 014 deflectable guidewire, a next-generation guidewire specifically developed for neurovascular interventions, has received CE Mark certification under the European Medical Device Regulation (EU MDR). The SmartGUIDE™ 014 is engineered to support physicians in navigating the intricate and delicate blood vessels…
Read MoreBracco, Limula and UNIFR Join Forces to Create Efficient Cancer Cell Therapies
Cell and gene therapies are promising, but remain extremely expensive. The pharmaceutical company Bracco Imaging, a leader in medical imaging, Limula, a company specialising in the automation of cell therapies, and Professor Nicola Vannini of the University of Fribourg are joining forces to make them more accessible. This public-private partnership is receiving CHF 688,000 in…
Read MoreVivent Biosignals, global leader in digital crop diagnostics, raises CHF 7 Million
Vivent Biosignals, the Vaud-based pioneer of “wearables for plants”, has announced new investment from Agri Investment Fund (AIF), Horticoop, Pymwymic and Swiss private investors. The funding will accelerate Vivent’s commercial scaling of its breakthrough plant biosignal monitoring technology, which is transforming crop management and sustainable food production. “We are thrilled to welcome Agri Investment Fund…
Read MoreThe Swiss Health Valley Shines with Multiple Innovation Awards
The Swiss Health Valley continues to demonstrate its strength as a European powerhouse in life sciences, medtech, and biotechnology. In recent weeks, several startups and innovators from our ecosystem have been honoured with prestigious awards, highlighting the region’s exceptional dynamism and creativity. MoleSense wins the Swiss Innovation Challenge Before an audience of nearly 4,000 people,…
Read MoreBiofactory Competence Center (BCC): A Swiss Hub for Applied Biotech Innovation
Since its founding in 2015, the Biofactory Competence Center (BCC) in Fribourg is a unique biopharmaceutical training and research institution in Switzerland and part of HEIA-FR, the School of Engineering and Architecture of Fribourg. The center has grown into a pivotal player in the Swiss biotech landscape. Located at the crossroads of applied research, industry…
Read MoreDistalmotion secures $150 Million to expand robotic surgery system in US
The Biopôle-based company (Vaud) developed the DEXTER® Robotic Surgery System, a soft tissue surgical robot that uniquely simplifies operations to make the benefits of wristed robotics accessible in any operating room (OR). This new funding will be used primarily to accelerate US commercial adoption of DEXTER, its soft tissue robotic surgery system, as well as to…
Read MoreWomen Scientists Shaping the Future of Health and Science in the Swiss Health Valley
From neurology to nanotechnology, and from molecular biology to cancer immunology, women scientists across the Swiss Health Valley are driving discovery, innovation, and impact.
Read MoreInSphero acquires DOPPL SA and Sun Bioscience Gri3D Technology
InSphero AG, the global market leader in 3D cell-based assays and organ-on-chip systems signed the definitive agreement to acquire DOPPL SA, a Lausanne-based innovator in the organoid space, including the Sun Bioscience Gri3D® technology.
Read More